Trade BDSX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Biodesix, Inc. (BDSX) is trading at US$26.18, down 1.11% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$280.98M. Over the past 52 weeks, BDSX has traded between US$5.26 and US$31.31. On Syfe you can trade BDSX with $0 commission and add it to your watchlist.
| Previous close | US$26.48 |
|---|---|
| Market cap | US$280.98M |
| 52-week range | US$5.26 – US$31.31 |
| Volume | 58.75K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Biodesix, Inc.
Biodesix, Inc. operates as a diagnostic solutions company. It engages in providing blood-based diagnostic tests and development services. The firm offers five diagnostic tests, including Nodify CDT, Nodify XL2, GeneStrat ddPCR, GeneStrat NGS, and VeriStrat. The company was founded by David Brunel and Robert E. Cawthorn in 2005 and is headquartered in Louisville, CO.
Year: 2020
Roth Capital Initiates Biodesix at Buy With $32 Price Target
Jun 25, 11:36 AM · MT Newswires
HC Wainwright Initiates Biodesix at Buy With $26 Price Target
Jun 15, 10:27 AM · MT Newswires
Top Premarket Gainers
May 5, 12:02 PM · MT Newswires
Biodesix, Inc. (BDSX) stock is trading at US$26.18, -1.11% from the previous close of US$26.48.
The market cap for Biodesix, Inc. (BDSX) stock is approximately US$280.98M.
The 52-week high for Biodesix, Inc. (BDSX) stock is US$31.31.
The 52-week low for Biodesix, Inc. (BDSX) stock is US$5.26.
Biodesix, Inc. (BDSX) does not currently pay a dividend.
Stay on top of BDSX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
